Many professional truck drivers suffer from low back pain (LBP) which is thought to be associated with exposure to whole-body vibration (WBV). The objectives of this study were to: (i) characterize general health, regional body pain and WBV exposures, (ii) evaluate the associations between different WBV parameters and health outcomes, and (iii) determine whether there were factors which affect a truck driver's WBV exposures. This study analyzed WBV exposures from 96 long-haul truck drivers over their regular work shift (6-15h) per International Standards Organization (ISO) 2631-1 and 2631-5 WBV standards. This study also evaluated regional body pain (10-point scale), low back disability (the Oswestry Disability Index), and physical and mental health (the Short Form 12-item Health Survey). The results demonstrated that the daily vector sum WBV exposures [A(8), VDV(8) and Sed(8)] were above action limits while the predominant z-axis exposures were below action limits. Among all the musculoskeletal outcomes, LBP was the most prevalent (72.5%) with average LBP score of 2.9 (SD: 2.0). The SF-12 health scores demonstrated that truck drivers in general had lower physical health status than the general US population (P's < 0.04) and that physical health status decreased as WBV exposures increased (P = 0.03). In addition, the correlations between the WBV measures and health outcomes indicated that A(8) exposure measures had a stronger link to musculoskeletal (LBP) and other health outcomes than the VDV(8) and Sed(8) measures. Finally, seat manufacturer and seat age were two factors which had a strong influence on WBV exposures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.